Research compound supplied in Australia by Pulse Biolabs for laboratory use. Available in 10mg.
Kisspeptin is the brain signal that switches on the chain of reproductive hormones. Research asks how that first step is controlled, and what happens when it is given.
Kisspeptin is a family of peptides from the KISS1 gene, supplied as a single synthetic form, that act on the KISS1R receptor on the neurons controlling reproductive hormone release. It is studied as a key upstream regulator of the chain that runs from the brain to the ovaries and testes. Evidence comes from human genetics and small clinical studies: hormone responses in healthy volunteers, and mature eggs and pregnancies in a 53-woman IVF study. None establishes a registered treatment.
Read the full research note →| Presentation | Code | Status | Price |
|---|---|---|---|
| 10mg | KS10 | In stock | $115 |
No batch-specific test report is currently published for this product. What a report does and does not show.
Supplied as lyophilised (freeze-dried) powder in a sealed vial. Store sealed and protected from light at the conditions stated on the product label or supplied specification. Solvent choice, concentration and handling after reconstitution depend on the compound and on the laboratory’s own procedures, and are not specified here.
Kisspeptin is not an approved medicine in Australia and is not separately listed in the Poisons Standard (June 2026). No regulator has approved a kisspeptin medicine. In sport, kisspeptin and its agonist analogues are listed under S2.2.1 (testosterone-stimulating peptides in males) of the 2026 WADA Prohibited List, prohibited at all times in males.
Status checked 2026-09-23. Details and sources in the research note.